Showing results (181-190 of 220) with videos related to

Sort By:
Pageof 22
Cellular Microbiology|June 9, 2006
Citrobacter rodentium infection causes both mitochondrial dysfunction and intestinal epithelial barrier disruption in vivo: role of mitochondrial associated protein (Map)Caixia Ma, Mark E Wickham, Julian A Guttman, et al.
Oncoimmunology|June 2, 2026
Dectin-1 signaling promotes Galectin-3 shedding and expansion of immunosuppressive CD71+ erythroid cells in breast cancerAko Azimi, Amirhossein Rahmati, Shima Shahbaz, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|January 24, 2025
Assessing the effects of immune checkpoint inhibitors on bone utilizing machine learning-assisted opportunistic quantitative computed tomographyBryn E Matheson, Jacob L Jaremko, Alexandra Dowhanik, et al.
Molecular Biology and Evolution|April 29, 2005
Host switch leads to emergence of Plasmodium vivax malaria in humansJianbing Mu, Deirdre A Joy, Junhui Duan, et al.
Biological Psychiatry|March 31, 2004
Acute vagus nerve stimulation using different pulse widths produces varying brain effectsQiwen Mu, Daryl E Bohning, Ziad Nahas, et al.
Plos One|November 21, 2022
"3D, human renal proximal tubule (RPTEC-TERT1) organoids 'tubuloids' for translatable evaluation of nephrotoxins in high-throughput"Sarah E Vidal Yucha, Doug Quackenbush, Tiffany Chu, et al.
Plos One|June 1, 2012
Patients with inflammatory bowel disease exhibit dysregulated responses to microbial DNANaomi S C Hotte, Saad Y Salim, Robert H Tso, et al.
Biotechnology and Bioengineering|May 29, 2021
High-throughput CRISPR-mediated 3D enrichment platform for functional interrogation of chemotherapeutic resistanceTaraka S P Grandhi, Jeremy To, Angelica Romero, et al.
Nature Communications|April 20, 2018
Induction of muscle stem cell quiescence by the secreted niche factor Oncostatin MSrinath C Sampath, Srihari C Sampath, Andrew T V Ho, et al.
Ebiomedicine|August 15, 2019
Biodistribution, shedding, and transmissibility of the oncolytic virus talimogene laherparepvec in patients with melanomaRobert H I Andtbacka, Thomas Amatruda, John Nemunaitis, et al.
Pageof 22